BD FACSLyric™ Flow Cytometer System with BD Multitest™ Assays Offers Reliability and Consistency Jul 19, 2017 FRANKLIN LAKES, N.J., July 19, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyric™... Read more
Shimadzu’s Nexis GC-2030, the company’s latest high-end gas chromatograph, and the HS-20/HS-10 headspace samplers can now be controlled by OpenLAB CDS, the chromatography data system from Agilent Technologies, Inc. Shimadzu will release an upgraded GC driver in order to control the Nexis GC-2030 and the HS-20/HS-10 using OpenLAB CDS. Other instruments controlled by OpenLAB CDS... Read more
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 18, 2017– Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop... Read more
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 18, 2017– Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop... Read more
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif., July 18, 2017 Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop... Read more
Samco Clicktainer vials provide secure and reliable sample collection and transport Thermo Scientific Sterilin containers suitable for molecular biology and genomic and forensic applications WALTHAM, Mass., July 11, 2017 /PRNewswire/ — For the rigorous requirements of molecular biology, genomic and forensic research facilities, new universal containers are specifically lot tested and certified to be free from RNase, DNase,... Read more
Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven Fluidigm® microfluidic technology.... Read more
Precision ID GlobalFiler NGS STR Panel v2 and Converge 2.0 software enable retrieval of more data from mixed and degraded samples CARLSBAD, Calif., July 18, 2017 /PRNewswire/ — Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to a new next-generation sequencing (NGS)... Read more
Influential MIT Researcher Recognized for Advancing the Use of Analytical Techniques and Multilayer Analysis for Characterization of Biopharmaceuticals SANTA CLARA, Calif., July 18, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Ram Sasisekharan, Ph.D., has received an Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization. A more... Read more
SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications based on the PacBio® Sequel® System. New applications developed under this agreement... Read more